Integra LifeSciences Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides 2023 Financial Guidance
22 févr. 2023 06h00 HE
|
Integra LifeSciences Holdings Corporation
PRINCETON, N.J., Feb. 22, 2023 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART) today reported financial results for the fourth quarter and full year ended December 31,...
Integra LifeSciences to Host Fourth Quarter 2022 Financial Results Conference Call on February 22, 2023
09 févr. 2023 07h30 HE
|
Integra LifeSciences Holdings Corporation
PRINCETON, N.J., Feb. 09, 2023 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release fourth quarter 2022 financial...
Integra LifeSciences Reports Select Preliminary Fourth Quarter and Full-Year 2022 Financials
10 janv. 2023 16h30 HE
|
Integra LifeSciences Holdings Corporation
Fourth Quarter 2022 Fourth quarter 2022 revenue is expected to be in a range of $397 million to $398 million, representing a decrease of approximately 2% on a reported basis and an increase of...
Integra LifeSciences to Present at 41st Annual J.P. Morgan Healthcare Conference
21 déc. 2022 17h00 HE
|
Integra LifeSciences Holdings Corporation
PRINCETON, N.J., Dec. 21, 2022 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that Jan De Witte, president...
Integra LifeSciences Completes the Acquisition of Surgical Innovation Associates
06 déc. 2022 17h00 HE
|
Integra LifeSciences Holdings Corporation
PRINCETON, N.J., Dec. 06, 2022 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced it has successfully completed...
Integra LifeSciences Announces Definitive Agreement to Acquire Surgical Innovation Associates (SIA) and Plans for $150 Million Share Repurchase
01 déc. 2022 08h00 HE
|
Integra LifeSciences Holdings Corporation
Acquisition will add distinct new product solution for plastic and reconstructive surgery to address clinical needs and improve patient outcomes Deploys capital to support strong profitable growth...
Integra LifeSciences Reports Third Quarter 2022 Financial Results
26 oct. 2022 06h01 HE
|
Integra LifeSciences Holdings Corporation
PRINCETON, N.J., Oct. 26, 2022 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today reported financial results for the...
Integra LifeSciences to Host Third Quarter 2022 Financial Results Conference Call on October 26, 2022
07 oct. 2022 16h30 HE
|
Integra LifeSciences Holdings Corporation
PRINCETON, N.J., Oct. 07, 2022 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release third quarter 2022 financial...
Integra LifeSciences Announces Key Executive Appointment
06 oct. 2022 16h10 HE
|
Integra LifeSciences Holdings Corporation
PRINCETON, N.J., Oct. 06, 2022 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART) today announced the appointment of Harvinder Singh as executive vice president and...
Integra LifeSciences Publishes Its Inaugural ESG Report
29 sept. 2022 08h30 HE
|
Integra LifeSciences Holdings Corporation
PRINCETON, N.J., Sept. 29, 2022 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today issued its inaugural Environmental,...